News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,909 Results
Type
Article (5818)
Company Profile (20)
Press Release (239071)
Section
Business (87638)
Career Advice (470)
Deals (16469)
Drug Delivery (9)
Drug Development (21229)
Employer Resources (32)
FDA (4046)
Job Trends (4548)
News (129714)
Policy (8412)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (336)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16186)
ALS (21)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (15)
Approvals (4066)
Artificial intelligence (47)
Autoimmune disease (5)
Automation (3)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (71)
Cancer (513)
Cardiovascular disease (26)
Career advice (402)
Career pathing (3)
CAR-T (32)
Cell therapy (107)
Cervical cancer (2)
Clinical research (17764)
Collaboration (192)
Compensation (170)
Complete response letters (3)
COVID-19 (450)
CRISPR (7)
C-suite (108)
Cystic fibrosis (17)
Data (578)
Depression (7)
Diabetes (48)
Diagnostics (2254)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (26)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (42781)
Editorial (2)
Employer branding (6)
Employer resources (33)
Events (40477)
Executive appointments (330)
FDA (4314)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (225)
Gene editing (16)
Generative AI (2)
Gene therapy (50)
GLP-1 (124)
Government (507)
Guidances (17)
Healthcare (5565)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (469)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8401)
IRA (3)
Job creations (1258)
Job search strategy (365)
Kidney cancer (7)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2674)
Liver cancer (17)
Lung cancer (58)
Lymphoma (33)
Management (11)
Manufacturing (56)
MASH (28)
Medical device (4305)
Medtech (4307)
Mergers & acquisitions (8303)
Metabolic disorders (130)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (425)
NextGen: Class of 2025 (1792)
Non-profit (789)
Northern California (942)
Now hiring (3)
Obesity (55)
Opinion (31)
Ovarian cancer (17)
Pain (15)
Pancreatic cancer (20)
Parkinson's disease (28)
Partnered (8)
Patents (27)
Patient recruitment (30)
Peanut (5)
People (26436)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5263)
Phase II (7828)
Phase III (6113)
Pipeline (566)
Policy (9)
Postmarket research (658)
Preclinical (2088)
Press Release (67)
Prostate cancer (29)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (72)
Real estate (2013)
Recruiting (9)
Regulatory (5639)
Reports (15)
Research institute (350)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (26)
Series A (29)
Series B (23)
Service/supplier (2)
Sickle cell disease (8)
Southern California (714)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (5)
Startups (1122)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (4)
United States (7574)
Vaccines (59)
Venture capitalists (3)
Weight loss (22)
Women's health (1)
Date
Today (66)
Last 7 days (188)
Last 30 days (846)
Last 365 days (11159)
2025 (3320)
2024 (12203)
2023 (14505)
2022 (20417)
2021 (21845)
2020 (19698)
2019 (14289)
2018 (11001)
2017 (10866)
2016 (9994)
2015 (13151)
2014 (10360)
2013 (8347)
2012 (9039)
2011 (9443)
2010 (9255)
Location
Africa (199)
Alabama (14)
Alaska (2)
Arizona (66)
Arkansas (1)
Asia (12165)
Australia (1670)
California (1988)
Canada (1079)
China (77)
Colorado (90)
Connecticut (96)
Delaware (34)
Europe (25889)
Florida (285)
Georgia (38)
Idaho (23)
Illinois (116)
India (7)
Indiana (80)
Iowa (1)
Japan (78)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (222)
Massachusetts (1622)
Michigan (105)
Minnesota (146)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (14)
Nevada (26)
New Hampshire (23)
New Jersey (696)
New Mexico (8)
New York (524)
North Carolina (351)
North Dakota (2)
Northern California (942)
Ohio (57)
Oklahoma (7)
Oregon (4)
Pennsylvania (383)
Puerto Rico (2)
Rhode Island (13)
South America (307)
South Carolina (5)
Southern California (714)
Tennessee (44)
Texas (274)
Utah (63)
Virginia (46)
Washington D.C. (9)
Washington State (181)
West Virginia (2)
Wisconsin (32)
244,909 Results for "nevro corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
February 6, 2025
·
8 min read
Press Releases
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
March 4, 2025
·
18 min read
Biotech Bay
Nevro to Present at Truist Securities MedTech Conference
Nevro Corp. announced that members of its management team will participate in a “fireside chat” session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.
June 11, 2024
·
2 min read
Deals
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - June 28, 2024
Nevro Corp. announced that on June 7, 2024, the Compensation Committee of the Company’s Board of Directors granted inducement restricted stock unit awards covering 56,692 shares of Nevro’s common stock to 17 new non-executive employees to induce them to accept employment with Nevro.
June 28, 2024
·
2 min read
Biotech Bay
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Corp. announced that on May 7, 2024, the Compensation Committee of the Company’s Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro’s common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro.
May 24, 2024
·
2 min read
Business
Nevro Reports First-Quarter 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results.
May 7, 2024
·
19 min read
Biotech Bay
Nevro to Present at BofA Securities 2024 Healthcare Conference
Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that members of its management team will participate in the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, 2024.
May 9, 2024
·
2 min read
Business
Nevro Enters Into Cooperation Agreement With Engaged Capital
Nevro Corp. announced that it has entered into a Cooperation Agreement with Engaged Capital, LLC, pursuant to which Kirt P. Karros has been appointed to Nevro’s Board of Directors as well as the Audit Committee of the Board effective February 20, 2024.
February 21, 2024
·
4 min read
Press Releases
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results
January 13, 2025
·
7 min read
Business
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Nevro Corp. today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024.
April 17, 2024
·
2 min read
1 of 24,491
Next
